NVS vs TARS
NVS (NVS) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
NVS (NVS) common stock.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
NVS does not have a complete income-statement cache yet.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
NVS currently screens at market cap $0. TARS currently screens at market cap $2.66B.
Not investment advice. Open the NVS and TARS stock pages for the full models.
Not investment advice.